Nuvalent (NUVL) Other Non Operating Income (2020 - 2026)
Nuvalent (NUVL) posted Other Non Operating Income of -$2.6 million for Q1 2026, down 109.38% on a QoQ basis from $27.4 million in Q4 2025, and down 79.72% year-over-year from -$12.7 million in Q1 2025.
Nuvalent (NUVL) Other Non Operating Income (2020 - 2026) Analysis & Trends
Nuvalent's Other Non Operating Income history runs 6 years deep, the most recent figure standing at -$2.6 million for Q1 2026.
- Quarterly Other Non Operating Income fell 79.72% year-over-year to -$2.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.0 million (up 94.7% YoY) and the FY2025 annual result came in at $113000.0, up 100.63% from the prior year.
- Other Non Operating Income was -$2.6 million for Q1 2026 at Nuvalent, down from $27.4 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $27.4 million in Q4 2025 and bottomed at -$19.8 million in Q3 2025.
- A 4-year average of -$1.9 million and a median of -$1.3 million in 2024 frame the typical range for Other Non Operating Income.
- Peak annual rise in Other Non Operating Income reached 67100.0% in 2022, while the deepest fall reached 1311.24% in 2022.
- Nuvalent's Other Non Operating Income stood at -$1.1 million in 2022, then declined by 24.3% to -$1.3 million in 2024, then surged by 2144.25% to $27.4 million in 2025, then sank by 109.38% to -$2.6 million in 2026.
- Business Quant data shows NUVL's Other Non Operating Income at -$2.6 million in Q1 2026, $27.4 million in Q4 2025, and -$19.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Nuvalent | 9.75 Bn | 9.75 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.57 Mn |
| Dec 31, 2025 | 27.39 Mn |
| Sep 30, 2025 | -19.81 Mn |
| Jun 30, 2025 | -6.04 Mn |
| Mar 31, 2025 | -1.43 Mn |
| Dec 31, 2024 | -1.34 Mn |
| Sep 30, 2024 | -16.60 Mn |
| Dec 31, 2022 | -1.08 Mn |
| Sep 30, 2022 | 672,000.00 |
| Jun 30, 2022 | 267,000.00 |
| Mar 31, 2022 | 139,000.00 |
| Dec 31, 2021 | 89,000.00 |
| Sep 30, 2021 | 1,000.00 |
| Jun 30, 2021 | 12,000.00 |
| Mar 31, 2021 | 12,000.00 |
| Dec 31, 2020 | -3,000.00 |
| Sep 30, 2020 | -14,000.00 |
| Jun 30, 2020 | -9,000.00 |